Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWegovy does not list insomnia or disrupted sleep as a recognised side effect in its licensed prescribing information, but many people starting semaglutide do notice changes to how well they sleep, particularly in the early weeks of treatment. The honest answer is that the relationship between Wegovy and sleep is more complicated than a simple yes or no. Nausea, vivid dreams, and reflux (all documented effects of the medicine) can interrupt sleep without sleep itself being the direct target. These are prescription-only medicines that a clinician reviews before prescribing; the information below explains what is known, what is still debated, and when to seek advice.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
When people search whether Wegovy can cause sleep problems, there is often an assumption that the medicine is acting on the nervous system in a way that directly suppresses sleep. That picture is not well supported by the clinical evidence. The NHS semaglutide medicines page lists the recognised common side effects (nausea, vomiting, diarrhoea, constipation, headache, dizziness) and sleep disruption does not appear among them.
What the clinical data does show is that semaglutide slows gastric emptying and reduces appetite, and both of those effects can have knock-on consequences at night. Eating later in the evening with a slower-emptying stomach raises the likelihood of reflux when you lie flat. Nausea that has been manageable during the day can feel more intrusive once the distractions of normal life stop. Neither of those is the medicine keeping you awake in a neurological sense; they are secondary effects of the GI changes that are well-recognised and usually temporary.
If you have been reading about semaglutide and stomach problems alongside this question, you will recognise that thread: most sleep complaints in early treatment trace back to gut symptoms rather than anything happening to sleep itself.
There are several real, evidence-backed mechanisms worth understanding. First, nausea is listed as the most common side effect — occurring in the majority of people at some point, particularly around dose increases. If nausea arrives in waves at night, sleep quality suffers. Timing your injection is not something to change without speaking to a prescriber, but it is worth discussing if night-time nausea is a pattern; the common problems people experience on semaglutide page covers that in more detail.
Second, obstructive sleep apnoea is a recognised weight-related condition and one of the qualifying comorbidities under the medicine's licensed eligibility criteria. As body weight falls, apnoea episodes often reduce. This means that early in treatment, before meaningful weight loss has accumulated, sleep may feel no different or even temporarily disturbed as breathing patterns shift. Later, many patients report their sleep is noticeably better, which would show up as a sleep change that is easy to misattribute to the medication itself.
Third, anecdotal reports of vivid or unusual dreams circulate widely on patient forums. This is not a finding that appears in large trial data, but it has been raised with Novo Nordisk and the MHRA. The Yellow Card scheme at yellowcard.mhra.gov.uk exists precisely for side effects like this: reporting them helps build the post-market safety picture for all GLP-1 medicines.
One area where semaglutide and sleep intersect in a clearly positive direction is obstructive sleep apnoea. Clinical trials studying cardiovascular outcomes with semaglutide included patients with sleep apnoea in their populations, and weight reduction consistently correlates with improvement in apnoea severity scores. If you have sleep apnoea and are considering weight-loss treatment, that context is worth raising during your consultation, because it affects which medicine and which monitoring approach might suit you best.
For people asking whether Wegovy causes sleep problems because they are already experiencing disruption, the more useful clinical question is: which specific symptom is interfering? Reflux at night calls for different practical steps than anxiety-related wakefulness or changes to dream content. Our prescribers at our clinical team page can give you a fuller picture of how semaglutide tends to settle in over time, and at what point ongoing sleep difficulty would warrant a clinical review. You can also read about semaglutide more broadly on our semaglutide information page.
A few straightforward adjustments are worth considering while you wait for GI symptoms to settle. Avoid eating within two to three hours of lying down, particularly important given how semaglutide slows gastric emptying. Keep your injection pen in the fridge door as a reminder to use it consistently on the same day each week; irregular timing can make side-effect patterns harder to predict. Propping yourself up slightly if reflux is the culprit, and reducing very fatty or spicy food in the evening, are both steps the NHS recommends for reflux management generally.
If sleep problems persist beyond the first few weeks at a given dose, or are severe enough to affect daily functioning, that is not something to wait out silently. The Wegovy and sleep page goes deeper on lifestyle measures, and the NHS semaglutide page lists the full side-effect profile to compare against what you are experiencing. Thinking about the wider picture of treatment (including what Wegovy costs in the private market and what that includes in terms of ongoing clinical support) is also relevant, because access to a prescriber when questions come up matters as much as the medicine itself.
If anything feels unexpected or worrying, you can also review whether Wegovy affects vision, another question that comes up in this space, and report any new symptoms to the MHRA. Starting a free consultation with nume means a prescriber reviews your full health picture before anything is prescribed, with aftercare available seven days a week so questions like this one get a clinical answer rather than a search result.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.